-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RnV8PLhXjyMd7pcLFBecj6DyGXV9DUVJ/vyU5zRK97POI8XHQucEJ9IhlTfRbCkt CvRhVAPaKbh3QcjhSIugvA== 0001209191-10-044025.txt : 20100826 0001209191-10-044025.hdr.sgml : 20100826 20100826143447 ACCESSION NUMBER: 0001209191-10-044025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100824 FILED AS OF DATE: 20100826 DATE AS OF CHANGE: 20100826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ECLIPSYS CORP CENTRAL INDEX KEY: 0001034088 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 650632092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: THREE RAVINIA DRIVE CITY: ATLANTA STATE: GA ZIP: 30346 BUSINESS PHONE: 404-847-5000 MAIL ADDRESS: STREET 1: THREE RAVINIA DRIVE CITY: ATLANTA STATE: GA ZIP: 30346 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOMEZ JOHN CENTRAL INDEX KEY: 0001266354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24539 FILM NUMBER: 101040248 MAIL ADDRESS: STREET 1: THREE RAVINIA DRIVE CITY: ATLANTA STATE: GA ZIP: 30346 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-08-24 1 0001034088 ECLIPSYS CORP ECLP 0001266354 GOMEZ JOHN THREE RAVINIA DRIVE ATLANTA GA 30346 0 1 0 0 Exec. Vice President Common Stock 2010-08-24 4 D 0 63750 D 0 D Stock Option 13.26 2010-08-24 4 D 0 459 0.00 D Common Stock 459 0 D Stock Option 13.26 2010-08-24 4 D 0 29541 0.00 D Common Stock 29541 0 D Stock Option 11.95 2010-08-24 4 D 0 40941 0.00 D Common Stock 40941 0 D Stock Option 11.95 2010-08-24 4 D 0 9059 0.00 D Common Stock 9059 0 D Stock Option 13.35 2010-08-24 4 D 0 116000 0.00 D Common Stock 116000 0 D Stock Option 13.35 2010-08-24 4 D 0 4000 0.00 D Common Stock 4000 0 D Stock Option 19.70 2010-08-24 4 D 0 2365 0.00 D Common Stock 2365 0 D Stock Option 19.70 2010-08-24 4 D 0 137635 0.00 D Common Stock 137635 0 D Stock Option 22.07 2010-08-24 4 D 0 35000 0.00 D Common Stock 35000 0 D Stock Option 7.97 2010-08-24 4 D 0 45000 0.00 D Common Stock 45000 0 D Stock Option 7.97 2010-08-24 4 D 0 60000 0.00 D Common Stock 60000 0 D Performance Stock Units 0.00 2010-08-24 4 D 0 50000 0.00 D Common Stock 50000 0 D As the transaction was fully described in the joint proxy statement dated July 14, 2010, as filed with the SEC, each Issuer share was converted into 1.2 shares of common stock of Allscripts Healthcare Solutions, Inc. pursuant to a merger of Issuer with a wholly-owned subsidiary of Allscripts. Shares that were converted included 6,250 shares of Issuer unvested restricted stock that will be subject to the same terms as specified in the original grant. Disposition by Reporting Person was approved by Issuer board of directors. In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. This option was fully vested. Disposition by Reporting Person was approved by Issuer board of directors. In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 21,146 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors. In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 15,938 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors. In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 21,250 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors. Each Performance Stock Unit ("PSU") represented a contingent right to receive a number of shares of Issuer's common stock ranging from 0 to 2.25, depending on the Issuer's Total Shareholder Return ("TSR") compared to the TSRs of a group of pre-selected companies in the healthcare technology and software industries over a performance period commencing on March 15, 2010 and ending on August 24, 2010, the effective date of the merger described above. As a result of the merger, each of the PSU's was converted into 1.2 shares of Allscripts common stock. Disposition by the Reporting Person was approved by Issuer's board of directors. /s/ John P. Gomez, by BWC, under POA 2010-08-26 -----END PRIVACY-ENHANCED MESSAGE-----